查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606391

兽医肿瘤学市场，按治疗类型、动物类型、癌症类型、产品类型、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Veterinary Oncology Market, By Therapy Type, By Animal Type, By Cancer Type, By Product Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年兽医肿瘤市场规模为11.0832亿美元，2024年至2032年复合年增长率为11.30%。

兽医肿瘤学市场-市场动态

宠物拥有量和支出的增加推动了兽医肿瘤学市场的需求

宠物拥有量的上升趋势和宠物医疗保健支出的增加正在推动兽医肿瘤学市场的显着成长。随着宠物越来越被视为家庭的一部分，宠物主人更愿意投资先进的医疗方法，包括癌症疗法，以确保宠物的健康。在可支配收入增加的支持下，这种态度的转变导致对兽医肿瘤服务的需求增加。此外，人们对宠物癌症的认识不断增强，以及专业治疗方法的出现，进一步促进了市场的扩张，凸显了该领域持续进步的迫切需求。

兽医肿瘤学市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 11.30% 左右的复合年增长率成长

根据动物类型细分，预计畜牧动物将在 2023 年显示最大的市场份额

根据治疗类型细分，化疗是2023年的主导类型

根据最终用户细分，兽医院是 2023 年的主导类型

按地区划分，亚太地区是 2023 年的主要收入来源

兽医肿瘤学市场-細項分析：

全球兽医肿瘤学市场根据治疗类型、动物类型、癌症类型、动物类型、最终用户和地区进行细分。

市场依动物类型分为两类：伴侣动物和家畜动物。人们越来越认识到动物福利的重要性，这延伸到疾病管理，包括癌症。农民和牲畜所有者正在投资改善动物的医疗保健，从而推动了对肿瘤服务的需求。牛、家禽和猪等牲畜对全球经济至关重要，提供肉类、乳製品和鸡蛋等食品。确保他们的健康，包括癌症治疗，对于防止经济损失至关重要。

市场依最终用户分为四大类：兽医院、兽医诊所、研究所、学术机构。兽医医院在兽医肿瘤市场中的高市占率可归因于几个因素。兽医医院是各种动物的初级保健中心，提供专门的癌症治疗，如化疗、放射治疗和手术。这些机构通常拥有先进的诊断工具、专业设备和熟练的兽医肿瘤学家，从而提高了患有癌症的宠物的护理品质。

兽医肿瘤学市场 - 地理洞察

在宠物拥有量增加、动物健康意识增强以及兽医诊断和治疗进步的推动下，亚太地区的兽医肿瘤学市场正在经历显着增长。中国、日本和印度等国家由于宠物数量的不断增长和先进兽医实践的采用，成为市场扩张的主要贡献者。日本以其先进的兽医医疗基础设施而闻名，而中国和印度则见证了宠物肿瘤学服务需求的快速增长。动物癌症盛行率不断上升，加上兽医专科诊所的发展和治疗选择范围的扩大，进一步推动了该地区的市场。

兽医肿瘤学市场-竞争格局：

兽医肿瘤学市场的竞争格局以提供一系列动物癌症诊断、治疗和先进治疗解决方案的主要参与者为标誌。 Zoetis Inc.、Elanco Animal Health 和 Merck Animal Health 等公司处于领先地位，利用其广泛的研究能力和产品组合来解决宠物的各种形式的癌症。这些市场领导者专注于创新疗法，例如标靶治疗和免疫疗法。此外，VetDC 和 AB Science 等小型公司和专业公司也因新型化疗和激酶抑制剂等利基产品而受到关注。合作、策略性收购和伙伴关係很常见，使参与者能够扩大其技术能力和影响力。对更有效、更安全的治疗的需求不断增长，以及宠物饲养和兽医护理的增加，继续推动该市场的竞争。

最新进展：

2024 年8 月，致力于加速动物健康领域生物製剂革命的Akston Biosciences Corporation 与普渡大学宣布建立策略伙伴关係，共同开发抗cPD-L1 单株抗体(mAb) 免疫疗法，用于治疗犬类癌症。

2024 年 9 月，开发宠物癌症治疗方法的生物製药公司 CureLab Veterinary Inc 宣布了一项 Regulation D 筹款计划，用于开发其基因疗法 ElenaVet，该疗法可增强人体的抗癌免疫反应并减少慢性发炎。此次发行是按照 D 条例第 506(c) 条进行的，该条例是根据 1933 年修订后的《证券法》颁布的。

目录

第 1 章：兽医肿瘤学市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按治疗类型分類的兽医肿瘤学市场片段
    • 按动物类型分類的兽医肿瘤学市场片段
    • 按癌症类型分類的兽医肿瘤学市场片段
    • 按产品类型分類的兽医肿瘤学市场片段
    • 最终用户的兽医肿瘤学市场片段
    • 按国家/地区分類的兽医肿瘤学市场摘要
    • 按地区分類的兽医肿瘤学市场片段
  • 竞争洞察

第 3 章：兽医肿瘤学主要市场趋势

  • 兽医肿瘤学市场驱动因素
    • 市场驱动因素的影响分析
  • 兽医肿瘤学市场限制
    • 市场限制影响分析
  • 兽医肿瘤学市场机会
  • 兽医肿瘤学市场未来趋势

第 4 章：兽医肿瘤学产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：兽医肿瘤学市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：兽医肿瘤学市场格局

  • 2023 年兽医肿瘤学市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：兽医肿瘤学市场 - 依治疗类型

  • 概述
    • 按治疗类型分類的细分市场份额分析
    • 化疗
    • 放射治疗
    • 免疫治疗
    • 手术
    • 标靶治疗
    • 联合疗法

第 8 章：兽医肿瘤学市场 - 依动物类型

  • 概述
    • 按动物类型分類的细分市场份额分析
    • 伴侣动物
      • 狗
      • 猫
    • 畜牧动物
      • 马匹
      • 牛
      • 其他的

第 9 章：兽医肿瘤学市场 - 按癌症类型

  • 概述
    • 按癌症类型分類的细分市场份额分析
    • 淋巴瘤
    • 肥大细胞癌
    • 乳癌
    • 黑色素瘤
    • 骨癌（骨肉瘤）
    • 血管肉瘤
    • 其他肿瘤（例如皮肤肿瘤、口腔肿瘤等）

第 10 章：兽医肿瘤学市场 - 依产品类型

  • 概述
    • 按动物类型分類的细分市场份额分析
    • 药品
      • 化疗药物
      • 标靶药物
      • 免疫治疗剂
    • 装置
      • 放射治疗设备
      • 影像设备（MRI、CT 扫描仪等）
      • 手术器械

第 11 章：兽医肿瘤学市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 兽医院
    • 兽医诊所
    • 研究所
    • 学术机构

第 12 章：兽医肿瘤学市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美兽医肿瘤学主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按治疗类型）
    • 北美市场规模和预测（按动物类型）
    • 北美市场规模和预测（按癌症类型）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲兽医肿瘤学主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按治疗类型）
    • 欧洲市场规模和预测（按动物类型）
    • 欧洲市场规模和预测（按癌症类型）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区兽医肿瘤学主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按治疗类型）
    • 亚太地区市场规模和预测（按动物类型）
    • 亚太地区市场规模和预测（按癌症类型）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲兽医肿瘤学主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按治疗类型）
    • 拉丁美洲市场规模与预测（按动物类型）
    • 拉丁美洲市场规模与预测（按癌症类型）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲兽医肿瘤学主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模和预测（按治疗类型）
    • 中东和非洲市场规模及预测（按动物类型）
    • 中东和非洲市场规模及预测（按癌症类型）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 13 章：主要供应商分析 - 兽医肿瘤学行业

  • 竞争仪表板
  • 公司简介
    • Zoetis Inc.
    • Boehringer Ingelheim Animal Health
    • Elanco Animal Health
    • Merck Animal Health (a division of Merck & Co., Inc.)
    • AB Science
    • Aratana Therapeutics
    • Regeneus Ltd
    • Varian Medical Systems
    • VetDC
    • Karyopharm Therapeutics
    • Others

第 14 章：360 度分析师视角

第 15 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4219

REPORT HIGHLIGHT

Veterinary Oncology Market size was valued at USD 1,108.32 million in 2023, expanding at a CAGR of 11.30% from 2024 to 2032.

The veterinary oncology market focuses on the diagnosis and treatment of cancer in animals, primarily companion animals like dogs and cats. It includes various services and products such as chemotherapy, immunotherapy, radiation therapy, and surgery. The rising pet ownership, growing awareness of animal health, and advancements in veterinary care have driven the market's growth. Additionally, the increasing incidence of cancer in pets and the availability of advanced diagnostic tools contribute to market expansion. The sector is supported by veterinary pharmaceutical companies and specialized clinics, with innovations in targeted therapies and personalized treatments enhancing the market's potential.

Veterinary Oncology Market- Market Dynamics

Increasing Pet Ownership and Spending Drives the Need for the Veterinary Oncology Market

The rising trend of pet ownership and increased spending on pet healthcare is driving significant growth in the veterinary oncology market. As pets are increasingly considered part of the family, pet owners are more willing to invest in advanced medical treatments, including cancer therapies, to ensure their pets' well-being. This shift in attitude, supported by higher disposable incomes, has resulted in greater demand for veterinary oncology services. Additionally, the growing awareness of pet cancers and the availability of specialized treatments have further contributed to market expansion, highlighting the crucial need for continued advancements in this field.

Veterinary Oncology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.30% over the forecast period (2024-2032)

Based on animal type segmentation, Livestock Animals was predicted to show maximum market share in the year 2023

Based on therapy type segmentation, Chemotherapy was the leading type in 2023

Based on end-user segmentation, Veterinary Hospitals was the leading type in 2023

Based on region, Asia Pacific was the leading revenue generator in 2023

Veterinary Oncology Market- Segmentation Analysis:

The Global Veterinary Oncology Market is segmented based on Therapy Type, Animal Type, Cancer Type, Animal Type, End User, and Region.

The market is divided into two categories based on animal type: Companion Animals, and Livestock Animals. There is increasing awareness about the importance of animal welfare, which extends to disease management, including cancer. Farmers and livestock owners are investing in better healthcare for their animals, driving demand for oncology services. Livestock animals, such as cattle, poultry, and swine, are vital to the global economy, providing food products like meat, dairy, and eggs. Ensuring their health, including cancer treatment, is critical to preventing economic losses.

The market is divided into four categories based on end users: Veterinary Hospitals, Veterinary Clinics, Research Institutes, and Academic Institutions. The high market share of veterinary hospitals in the veterinary oncology market can be attributed to several factors. Veterinary hospitals serve as primary care centers for a wide range of animals, offering specialized cancer treatments such as chemotherapy, radiation therapy, and surgery. These facilities often have access to advanced diagnostic tools, specialized equipment, and skilled veterinary oncologists, which enhances the quality of care for pets with cancer.

Veterinary Oncology Market- Geographical Insights

The veterinary oncology market in the Asia Pacific region is experiencing notable growth, driven by rising pet ownership, increasing awareness about animal health, and advancements in veterinary diagnostics and treatments. Countries like China, Japan, and India are key contributors to market expansion due to their growing pet populations and the adoption of advanced veterinary practices. Japan is particularly known for its sophisticated veterinary healthcare infrastructure, while China and India are witnessing rapid growth in demand for oncology services for pets. The increasing prevalence of cancer in animals, combined with the development of veterinary specialty clinics and an expanding range of treatment options, further propels the market in this region.

Veterinary Oncology Market- Competitive Landscape:

The competitive landscape of the veterinary oncology market is marked by key players offering a range of diagnostics, therapeutics, and advanced treatment solutions for animal cancers. Companies like Zoetis Inc., Elanco Animal Health, and Merck Animal Health are at the forefront, leveraging their extensive research capabilities and product portfolios to address various forms of cancer in pets. These market leaders focus on innovative therapies such as targeted treatments and immunotherapies. In addition, smaller companies and specialized firms, such as VetDC and AB Science, are also gaining traction with niche products like novel chemotherapies and kinase inhibitors. Collaborations, strategic acquisitions, and partnerships are common, allowing players to expand their technological capabilities and reach. The growing demand for more effective and safer treatments and increased pet ownership and veterinary care continue to drive competition in this market.

Recent Developments:

In August 2024, Akston Biosciences Corporation, which is dedicated to accelerating the biologics revolution in Animal Health, and Purdue University announced a strategic partnership to co-develop an anti-cPD-L1 monoclonal antibody (mAb) immunotherapy to treat cancer in dogs.

In September 2024, CureLab Veterinary Inc, a biopharmaceutical company that develops cancer treatments for pets, announced a Regulation D fundraising offer to develop its gene therapy, ElenaVet, which enhances the body's anticancer immune response and reduces chronic inflammation. The offering is being carried out in compliance with Rule 506(c) of Regulation D, which was issued under the amended Securities Act of 1933.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VETERINARY ONCOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Zoetis Inc.
  • Boehringer Ingelheim Animal Health
  • Elanco Animal Health
  • Merck Animal Health (a division of Merck & Co., Inc.)
  • AB Science
  • Aratana Therapeutics
  • Regeneus Ltd
  • Varian Medical Systems
  • VetDC
  • Karyopharm Therapeutics
  • Others

GLOBAL VETERINARY ONCOLOGY MARKET, BY THERAPY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Chemotherapy
  • Radiation Therapy
  • Immunotherapy
  • Surgery
  • Targeted Therapy
  • Combination Therapy

GLOBAL VETERINARY ONCOLOGY MARKET, BY ANIMAL TYPE - MARKET ANALYSIS, 2019 - 2032

  • Companion Animals
  • Dogs
  • Cats
  • Livestock Animals
  • Horses
  • Cattle
  • Others

GLOBAL VETERINARY ONCOLOGY MARKET, BY CANCER TYPE- MARKET ANALYSIS, 2019 - 2032

  • Lymphoma
  • Mast Cell Cancer
  • Mammary and Breast Cancer
  • Melanoma
  • Bone Cancer (Osteosarcoma)
  • Hemangiosarcoma
  • Other Tumors (e.g., Skin, Oral, etc.)

GLOBAL VETERINARY ONCOLOGY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Drugs
  • Chemotherapeutic Agents
  • Targeted Drugs
  • Immunotherapy Agents
  • Devices
  • Radiation Therapy Equipment
  • Imaging Devices (MRI, CT Scanners, etc.)
  • Surgical Instruments

GLOBAL VETERINARY ONCOLOGY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Veterinary Hospitals
  • Veterinary Clinics
  • Research Institutes
  • Academic Institutions

GLOBAL VETERINARY ONCOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Veterinary Oncology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Veterinary Oncology Market Snippet by Therapy Type
    • 2.1.2. Veterinary Oncology Market Snippet by Animal Type
    • 2.1.3. Veterinary Oncology Market Snippet by Cancer Type
    • 2.1.4. Veterinary Oncology Market Snippet by Product Type
    • 2.1.5. Veterinary Oncology Market Snippet by End User
    • 2.1.6. Veterinary Oncology Market Snippet by Country
    • 2.1.7. Veterinary Oncology Market Snippet by Region
  • 2.2. Competitive Insights

3. Veterinary Oncology Key Market Trends

  • 3.1. Veterinary Oncology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Veterinary Oncology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Veterinary Oncology Market Opportunities
  • 3.4. Veterinary Oncology Market Future Trends

4. Veterinary Oncology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Veterinary Oncology Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Veterinary Oncology Market Landscape

  • 6.1. Veterinary Oncology Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Veterinary Oncology Market - By Therapy Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Therapy Type, 2023 & 2032 (%)
    • 7.1.2. Chemotherapy
    • 7.1.3. Radiation Therapy
    • 7.1.4. Immunotherapy
    • 7.1.5. Surgery
    • 7.1.6. Targeted Therapy
    • 7.1.7. Combination Therapy

8. Veterinary Oncology Market - By Animal Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Animal Type, 2023 & 2032 (%)
    • 8.1.2. Companion Animals
      • 8.1.2.1. Dogs
      • 8.1.2.2. Cats
    • 8.1.3. Livestock Animals
      • 8.1.3.1. Horses
      • 8.1.3.2. Cattle
      • 8.1.3.3. Others

9. Veterinary Oncology Market - By Cancer Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Cancer Type, 2023 & 2032 (%)
    • 9.1.2. Lymphoma
    • 9.1.3. Mast Cell Cancer
    • 9.1.4. Mammary and Breast Cancer
    • 9.1.5. Melanoma
    • 9.1.6. Bone Cancer (Osteosarcoma)
    • 9.1.7. Hemangiosarcoma
    • 9.1.8. Other Tumors (e.g., Skin, Oral, etc.)

10. Veterinary Oncology Market - By Product Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Animal Type, 2023 & 2032 (%)
    • 10.1.2. Drugs
      • 10.1.2.1. Chemotherapeutic Agents
      • 10.1.2.2. Targeted Drugs
      • 10.1.2.3. Immunotherapy Agents
    • 10.1.3. Devices
      • 10.1.3.1. Radiation Therapy Equipment
      • 10.1.3.2. Imaging Devices (MRI, CT Scanners, etc.)
      • 10.1.3.3. Surgical Instruments

11. Veterinary Oncology Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 11.1.2. Veterinary Hospitals
    • 11.1.3. Veterinary Clinics
    • 11.1.4. Research Institutes
    • 11.1.5. Academic Institutions

12. Veterinary Oncology Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Veterinary Oncology Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Veterinary Oncology Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Veterinary Oncology Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Veterinary Oncology Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Veterinary Oncology Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Animal Type, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Veterinary Oncology Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. Zoetis Inc.
    • 13.2.2. Boehringer Ingelheim Animal Health
    • 13.2.3. Elanco Animal Health
    • 13.2.4. Merck Animal Health (a division of Merck & Co., Inc.)
    • 13.2.5. AB Science
    • 13.2.6. Aratana Therapeutics
    • 13.2.7. Regeneus Ltd
    • 13.2.8. Varian Medical Systems
    • 13.2.9. VetDC
    • 13.2.10. Karyopharm Therapeutics
    • 13.2.11. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us